QCORE
First North Stockholm
IT Services
Technology
Qlucore develops AI-based software for use in the healthcare sector. The company's precision medicine solutions transform genetic data into decision-making data to create the right treatment for patients. The company's first diagnostic test – for blood cancer in children – has been approved and CE-marked. The company also has tests for lung cancer under development, and is developing the Qlucore Omics Explorer analysis software.
Read moreRevenue M
EBIT-% (adj.)
EPS (adj.)
Dividend %
Interim report Q2'27
Interim report Q3'27
Annual report '27
Don't miss out - create an account and get all the possible benefits